RA Capital Management - AEROVATE THERAPEUTICS INC ownership

AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 18 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
RA Capital Management ownership history of AEROVATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$112,142,236
-20.9%
8,263,9820.0%2.21%
-17.5%
Q2 2023$141,727,291
-15.0%
8,263,9820.0%2.68%
-29.1%
Q1 2023$166,684,517
-31.2%
8,263,9820.0%3.77%
-23.2%
Q4 2022$242,134,673
+76.7%
8,263,9820.0%4.91%
+68.0%
Q3 2022$137,017,000
+6.1%
8,263,9820.0%2.92%
-15.1%
Q2 2022$129,166,000
-14.7%
8,263,9820.0%3.44%
+4.2%
Q1 2022$151,479,000
+55.5%
8,263,9820.0%3.30%
+92.4%
Q4 2021$97,432,000
-43.8%
8,263,9820.0%1.72%
-28.5%
Q3 2021$173,378,000
-8.1%
8,263,9820.0%2.40%
-20.7%
Q2 2021$188,667,0008,263,9823.03%
Other shareholders
AEROVATE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 3,758,686$78,857,0004.67%
RA Capital Management 8,263,982$173,378,0002.40%
Cormorant Asset Management, LP 2,030,691$41,962,0001.70%
SECTORAL ASSET MANAGEMENT INC 341,367$7,162,0000.60%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 714,285$14,986,0000.29%
Baker Brothers Advisors 1,652,171$34,663,0000.15%
Old Well Partners, LLC 12,600$264,0000.14%
Orbimed Advisors 535,714$11,239,0000.12%
Parkwood LLC 48,059$1,008,0000.12%
Darwin Global Management, Ltd. 12,484$262,0000.05%
View complete list of AEROVATE THERAPEUTICS INC shareholders